Promega has entered a strategic partnership with Watchmaker Genomics to license a novel engineered reverse transcriptase, the company announced today. According to a release, the enzyme will enhance Promega’s capabilities…
Imbed Biosciences recently announced the launch of SAM PainGuard with Lidocaine, which encompasses Surgaflex PainGuard for surgical wounds and Pelashield PainGuard for burn and trauma wound management. “Nearly 90% of…
Exact Sciences has entered into an exclusive agreement with Freenome, a biotechnology company pioneering an early cancer detection platform, the company announced recently. According to a release, Exact Sciences will…
Promega has committed to set near-term company-wide emission reductions with the Science Based Targets initiative (SBTi), the company announced recently. According to a release, this commitment begins a defined process…
Promega and Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, are partnering, the companies recently announced. According to…
Promega and Addgene, a purpose-driven organization helping scientists conduct experiments with greater ease, speed and reproducibility, have partnered, the companies recently announced. According to a release, the partnership will expand…
Exact Sciences‘ Oncodetect molecular residual disease (MRD) test has received Medicare coverage through the Centers for Medicare & Medicaid Services (CMS) Molecular Diagnostic Services Program (MolDX), the company announced recently….
SHINE Technologies has entered into a strategic partnership with Standard Nuclear, a reactor-agnostic producer of TRISO nuclear fuel and radioisotope power systems, SHINE announced today. According to a release, the…
Voximetry and Medpace Core Laboratories, a full-service core laboratory, have entered a strategic partnership aimed at enhancing radiopharmaceutical clinical trials through the integration of cutting-edge dosimetry technology and comprehensive contract…
Cellectar Biosciences and Nusano, a physics company transforming the production of radioisotopes, signed a multi-year supply agreement, the company announced recently. According to a release, Nusano will provide Cellectar with…
